Finance

Lists
HQY:NASDAQ
Healthequity Inc
$93.36
-2.82%
(-2.71) 1D
$93.36
0.00% (0.00)
After hours
Closed: Sep 8, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HQY...
Open
$95.54
High
$95.54
Low
$93.09
Mkt. cap
7.72B
Avg. vol.
808.02K
Volume
0.00
P/E ratio
33.74
52-wk high
$107.62
52-wk low
$72.76
EPS
$2.77
Beta
0.22
Shares outstanding
82.72M
No. of employees
3K
Open
$95.54
High
$95.54
Low
$93.09
Mkt. cap
7.72B
Avg. vol.
808.02K
Volume
0.00
P/E ratio
33.74
52-wk high
$107.62
52-wk low
$72.76
EPS
$2.77
Beta
0.22
Shares outstanding
82.72M
No. of employees
3K
Profile
HealthEquity, Inc. is an American financial technology and business services company that is designated as a non-bank health savings trustee by the IRS. This designation allows HealthEquity to be the custodian of health savings accounts regardless of which financial institution the funds are deposited with. As of July 31, 2022, HealthEquity managed 7.5 million HSA accounts, plus 7 million other consumer-directed benefits for total accounts of 14.5 million. Total HSA assets as of July 31, 2022 were $20.5 billion, including $13.1 billion of HSA cash and $7.4 billion of HSA investments. Wikipedia
About Healthequity Inc
CEOJon Kessler
Employees2.81K
FoundedJan 1, 2002
HeadquartersDraper, Utah, United States
SectorHealth care provider
Analyst ratings
Based on 10 analysts giving stock ratings to HQY in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for HQY in the last 3 months.
Highest
Current $93.36
$142.00 (+52.10%)
Average
$118.80 (+27.25%)
Lowest
$105.00 (+12.47%)
Analyst
Recommendation
Action
Price target
Projected
Date
Stan Berenshteyn
Wells Fargo
Buy
Reiterated
$125.00
+33.9%
09/03/2026
George Hill
Deutsche Bank
Buy
Reiterated
$142.00
+52.1%
08/31/2026
Alexander Paris
Barrington
Buy
Reiterated
$110.00
+17.8%
08/28/2026
Ryan Halsted
RBC Capital
Buy
Maintained
$108.00
+15.7%
08/27/2026
Sean Dodge
BMO Capital
Buy
Maintained
$105.00
+12.5%
08/28/2026
David Larsen
BTIG
Buy
Maintained
$115.00
+23.2%
08/28/2026
Peter Warendorf
Barclays
Buy
Maintained
$110.00
+17.8%
08/28/2026
Allen Lutz
Bank of America Securities
Buy
Reiterated
$125.00
+33.9%
08/28/2026
Scott Schoenhaus
KeyBanc
Buy
Maintained
$125.00
+33.9%
08/18/2026
Alexei Gogolev
J.P. Morgan
Buy
Reiterated
$123.00
+31.7%
06/25/2026
Constantine Davides
Citizens JMP
Buy
Maintained
$111.00
+18.9%
06/01/2026
David Roman
Goldman Sachs
Sell
Maintained
$88.00
-5.7%
05/29/2026
Daniel Perlin
RBC Capital
Buy
Reiterated
$100.00
+7.1%
03/17/2026
Brian Tanquilut
Jefferies
Buy
Maintained
$108.00
+15.7%
02/19/2026
Gregory Peters
Raymond James
Buy
Reiterated
$100.00
+7.1%
02/17/2026
Last report
Aug 27, 2026
Fiscal period
Q2 2027
EPS / Est. (USD)
$1.24 / $1.19
+3.91%beat
Revenue / Est. (USD)
350.73M / 349.23M
+0.43%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
322.16M
334.59M
354.64M
350.73M
Cost of goods sold
94.10M
106.44M
98.33M
92.78M
Cost of revenue
94.10M
106.44M
98.33M
92.78M
Research and development expenses
65.92M
70.35M
67.77M
73.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55.29M
58.45M
57.96M
58.08M
Operating expense
148.21M
155.75M
152.25M
158.29M
Total operating expenses
242.31M
262.19M
250.58M
251.07M
Operating income
79.85M
72.40M
104.07M
99.66M
Other non operating income
22.00K
329.00K
161.00K
20.00K
EBT including unusual items
67.53M
60.90M
92.41M
87.86M
EBT excluding unusual items
68.69M
62.22M
93.53M
88.84M
Income tax expense
15.84M
11.16M
23.00M
22.22M
Effective tax rate
23.46%
18.32%
24.88%
25.29%
Other operating expenses
-
-
-
-
Net income
51.69M
49.74M
69.42M
65.64M
Net profit margin
16.05%
14.87%
19.57%
18.72%
Earnings per share
1.01
0.95
1.24
1.24
Interest and investment income
2.86M
2.77M
1.89M
1.76M
Interest expense
-14.05M
-13.27M
-12.59M
-12.60M
Net interest expenses
-11.18M
-10.50M
-10.70M
-10.84M
Depreciation and amortization charges
-
-
-
-
EBITDA
118.63M
111.08M
142.28M
141.62M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps